AXOGEN ($AXGN) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of -$0.02 per share, missing estimates of $0.02 by $0.04. The company also reported revenue of $48,560,000, missing estimates of $49,290,357 by $-730,357.
You can see Quiver Quantitative's $AXGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AXOGEN Insider Trading Activity
AXOGEN insiders have traded $AXGN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:
- ERICK WAYNE DEVINNEY (Chief Innovation Officer) sold 15,111 shares for an estimated $264,442
- AMY MCBRIDE WENDELL sold 5,000 shares for an estimated $100,100
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AXOGEN Hedge Fund Activity
We have seen 78 institutional investors add shares of AXOGEN stock to their portfolio, and 86 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 828,410 shares (-86.3%) from their portfolio in Q4 2024, for an estimated $13,652,196
- DRIEHAUS CAPITAL MANAGEMENT LLC added 595,579 shares (+166.0%) to their portfolio in Q4 2024, for an estimated $9,815,141
- MORGAN STANLEY removed 469,947 shares (-16.2%) from their portfolio in Q4 2024, for an estimated $7,744,726
- FIRST LIGHT ASSET MANAGEMENT, LLC added 416,499 shares (+10.2%) to their portfolio in Q4 2024, for an estimated $6,863,903
- BALYASNY ASSET MANAGEMENT L.P. added 299,942 shares (+inf%) to their portfolio in Q4 2024, for an estimated $4,943,044
- INVESCO LTD. removed 260,294 shares (-93.8%) from their portfolio in Q4 2024, for an estimated $4,289,645
- JPMORGAN CHASE & CO removed 238,432 shares (-43.4%) from their portfolio in Q4 2024, for an estimated $3,929,359
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
